Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Molecular Response to Combined Molecular- and External Radiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC).
Rassamegevanon T, Feindt L, Koi L, Müller J, Freudenberg R, Löck S, Sihver W, Çevik E, Kühn AC, von Neubeck C, Linge A, Pietzsch HJ, Kotzerke J, Baumann M, Krause M, Dietrich A. Rassamegevanon T, et al. Among authors: sihver w. Cancers (Basel). 2021 Nov 9;13(22):5595. doi: 10.3390/cancers13225595. Cancers (Basel). 2021. PMID: 34830750 Free PMC article.
In reply to the Letter to the Editor by Chen and Lui regarding "Radiotherapy enhances uptake and efficacy of 90Y-cetuximab: A preclinical trial" by A Dietrich et al.
Dietrich A, Andreeff M, Koi L, Bergmann R, Schubert M, Schreiner L, Löck S, Sihver W, Freudenberg R, Hering S, Pietzsch HJ, Steinbach J, Kotzerke J, Baumann M, Krause M. Dietrich A, et al. Among authors: sihver w. Radiother Oncol. 2021 Aug;161:261-262. doi: 10.1016/j.radonc.2021.06.014. Epub 2021 Jun 11. Radiother Oncol. 2021. PMID: 34119587 No abstract available.
Radiotherapy enhances uptake and efficacy of 90Y-cetuximab: A preclinical trial.
Dietrich A, Andreeff M, Koi L, Bergmann R, Schubert M, Schreiner L, Löck S, Sihver W, Freudenberg R, Hering S, Pietzsch HJ, Steinbach J, Kotzerke J, Baumann M, Krause M. Dietrich A, et al. Among authors: sihver w. Radiother Oncol. 2021 Feb;155:285-292. doi: 10.1016/j.radonc.2020.11.013. Epub 2020 Nov 21. Radiother Oncol. 2021. PMID: 33227356 Free article.
Novel Tumor Pretargeting System Based on Complementary l-Configured Oligonucleotides.
Schubert M, Bergmann R, Förster C, Sihver W, Vonhoff S, Klussmann S, Bethge L, Walther M, Schlesinger J, Pietzsch J, Steinbach J, Pietzsch HJ. Schubert M, et al. Among authors: sihver w. Bioconjug Chem. 2017 Apr 19;28(4):1176-1188. doi: 10.1021/acs.bioconjchem.7b00045. Epub 2017 Mar 22. Bioconjug Chem. 2017. PMID: 28222590
Melanoma targeting with [99mTc(N)(PNP3)]-labeled α-melanocyte stimulating hormone peptide analogs: Effects of cyclization on the radiopharmaceutical properties.
Carta D, Salvarese N, Morellato N, Gao F, Sihver W, Pietzsch HJ, Biondi B, Ruzza P, Refosco F, Carpanese D, Rosato A, Bolzati C. Carta D, et al. Among authors: sihver w. Nucl Med Biol. 2016 Dec;43(12):788-801. doi: 10.1016/j.nucmedbio.2016.08.014. Epub 2016 Aug 31. Nucl Med Biol. 2016. PMID: 27694057
38 results